GPT and cancer: However, knockdown of ATRX is not sufficient to trigger the ALT pathway in telomerase-positive cell lines or to directly activate ALT in normal somatic cells, implying the existence of other necessary contributing factors involved in activation of ALT in cancer cells [92, 93].